中文 EN

News

news

position：Home > News

2026-04-03

Cygnus Biosciences Original Sequencing Platform Empowers Single-Cell Omics; Experimental Data Demonstrates Sequencing Capabilities

Recent experimental data has further robustly validated the GP1000 platform’s outstanding performance in single-cell transcriptomics.... ...

more

05-312023

Sequencing System GS100 Debuts as Major Scientific Achievement at 2023 Zhongguancun Forum

On the afternoon of May 30, the "Major Scientific and Technological Achievements Release Conference" of the 2023 Zhongguancun Forum was held in Beijing. The event unveiled 20 major achievements spanning four key areas: global scientific frontiers, the mai... ...

MORE >>

03-312023

Cygnus Bio Receives ISO 13485 Certification for Medical Device Quality Management Systems

Cygnus Biosciences (Beijing) Co., Ltd. successfully passed the TÜV Rheinland ISO 13485 audit for medical device quality management systems and obtained the certification. This marks that the quality management system of Cygnus Bio meets international requ... ...

MORE >>

03-202023

Cygnus Bio Completes Hundreds of Millions of Yuan in Series C+ Financing Round

In March 2023, Cygnus Bio secured another round of Series C+ financing totaling several hundred million yuan. The round was led by Source Code Capital, with participation from CCB Equity, E-Town Capital, Founder Heshang Capital, and Hetao Capital. This fo... ...

MORE >>

08-072022

Cygnus Bio Named on “2022 China Bio-pharmaceutical Industry Value List”

The 6th China Bio-pharmaceutical Innovation and Cooperation Conference & 2022 China Bio-pharmaceutical Industry Value List Awards Ceremony was successfully held recently, at which Cygnus Bio was honored on the “2022 China Bio-pharmaceutical Industry Value... ...

MORE >>

08-022022

Cygnus Bio Completes Over RMB 200 Million Series C+ Financing Round

In August 2022, Cygnus Biosciences (Beijing) Co., Ltd. (hereinafter referred to as Cygnus Bio), a company focused on the research and development of sequencing systems, announced the completion of a Series C+ financing round exceeding RMB 200 million. Thi... ...

MORE >>

12-272018

Cygnus Bio Awarded ＂Academician Expert Workstation＂ Designation

On the occasion of the upcoming New Year in late 2018, Cygnus Biosciences (Beijing) Co., Ltd. announced another piece of good news: it was officially awarded the designation of "Academician Expert Workstation" by the Beijing Association for Science and Te... ...

MORE >>